Caraco gets final FDA approval for generic Adipex
DETROIT Caraco Pharmaceuticals has been given final approval by the Food and Drug Administration for its application for the drug Phentermine Hydrochloride 37.5 mg, the generic of the short-term obesity management drug Adipex-P.
According to Caraco’s chief executive officer, Daniel H. Movens, the company is satisfied to receive the approval and is focusing “towards expanding our product line effectively, including products that are already available generically in the market that potentially can add measurable value.”
For the twelve months ending June 2007, Phentermine HCl generic and brand drugs have had combined annual sales of about $34 million. The new generic will be released immediately and will bring Caraco’s product total to 36.
United Supermarkets to open first health care clinics in west Texas
LUBBOCK, Texas United Supermarkets, a regional family-owned grocery chain with stores in 26 markets throughout north and west Texas is joining forces with Family Medicine Centers to offer a Living Well ExpressCare clinic in its Amarillo, Texas store beginning next month.
The clinic will offer primary medical services to store guests at United’s 45th and Bell location beginning Sept. 1. It will be located next to the pharmacy, allowing patients to get their prescriptions filled immediately at the same location.
United announced that similar facilities, the first in-store health clinics in west Texas, also are under construction in two United stores in Lubbock, as well as the new Market Street store being built in Frisco, near Dallas, according to the retailer.
“The need for accessible, affordable, high-quality health care in our country has never been greater, as studies indicate that nearly a third of the U.S. population does not have a family physician,” stated Mark Yowell, Specialty Division vice president of United Supermarkets. “[The clinics] “will allow us to focus attention on the wellness and nutrition products and services available in our stores.”
The facility will be open seven days a week, maintaining operating hours similar to those of the store’s pharmacy. It will be staffed by a licensed nurse practitioner or physician assistant under the supervision of a licensed physician.
FDA approves Acatvis’ generic Duragesic patch
MORRISTOWN, N.J. Actavis, the generic pharmaceutical company announced today that it has received approval from the Food and Drug Administration to market Fentanyl, the generic equivalent of the pain patch Duragesic.
President and chief executive officer Robert Wessmann said, “The addition of transdermal fentanyl is representative of our continued effort to expand the depth and breadth of our product portfolio, and highlights our product development expertise in specialty generic products.”
Annually, the brand and generic sales of Fentanyl in the U.S. were approximately $1.2 billion for the twelve months ending June 2007 according to IMS health data.